Ads
related to: abbvie stock price
Search results
Goldman Sachs Optimistic About Regenxbio's Gene Therapy Pipeline, Sees Over 160% Upside - Regenxbio...
Benzinga· 6 days agoGoldman Sachs initiates coverage on RGNX, citing potential of gene therapy platform.
Top law firms in US opioid lawsuits to get hundreds of millions in fees
Reuters· 6 days ago, opens new tab a pool of $2.13 billion in legal fees from nationwide drug industry settlements over the U.S. opioid crisis, with top firms set to receive hundreds of millions of dollars. Other ...
10 Best ETFs To Buy and Hold for Long-Term Growth
GoBankingRates via AOL· 1 day agoIf you're a long-term investor looking to diversify your growth portfolio, there are a number of exchange-traded funds that can help you reach your...
8 Lesser-Known Stocks To Bet on This Summer
GoBankingRates via AOL· 3 days agoThe stock market has been on a roll lately and some stocks have been skyrocketing. Artificial intelligence darling Nvidia is at the forefront, shooting...
Exploring Three Growth Companies With High Insider Ownership On Euronext Paris
Simply Wall St. via Yahoo Finance· 3 days agoAmid fluctuating global markets, France's CAC 40 Index has shown resilience with a modest uptick,...
These Biotech Stocks Hit New Highs, Did You Reap The Rewards?
RTT News· 6 days agoThe following compilation represents a selection of stocks featured on our website that reached new 52-week high levels during the current week. Protagonist is a clinical-stage biopharmaceutical ...
AbbVie's tight grip on Humira market raises concerns about biosimilars
Reuters· 6 days ago, opens new tab top-selling arthritis drug Humira has held onto more than 80% of patients after...
Exploring Three Euronext Paris Growth Companies With Significant Insider Ownership
Simply Wall St. via Yahoo Finance· 15 hours agoAmidst a backdrop of fluctuating global markets, France's CAC 40 Index has shown modest gains,...
REGENXBIO appoints new CEO, maintains financial outlook By Investing.com
Investing.com· 1 day agoBiotechnology firm REGENXBIO Inc. (NASDAQ:RGNX) on Wednesday announced a leadership transition, with...
Halozyme (HALO) Raises 2024 Financial Guidance, Stock Up 13%
Zacks via Yahoo Finance· 6 days agoHalozyme (HALO) gains 13% as it raises its full-year 2024 financial guidance and updates its...
